Thu, May 9, 2024
Wed, May 8, 2024
Tue, May 7, 2024

Scott Schoenhaus Maintained (ABCL) at Buy with Decreased Target to $7 on, May 8th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-7-on-may-8th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Scott Schoenhaus of Keybanc, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $8 to $7 on, May 8th, 2024.

Scott has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Scott's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Scott


  • Robert Wasserman of "Benchmark" Upgraded from Hold to Strong Buy on, Thursday, February 22nd, 2024
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $17 on, Wednesday, February 21st, 2024

Publication Contributing Sources